Robert Bostwick

Southern Research Institute — United States

Medicine · Health Sciences

16h-index842citations39works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(8), HIV Research and Treatment(5), COVID-19 Clinical Research Studies(3), SARS-CoV-2 and COVID-19 Research(3), Epigenetics and DNA Methylation(3)

Publications39 total

Targeting west nile virus replication by xanthine inhibitors
Medicinal Chemistry Research·2025· 1 cited
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay
Antiviral Research·2025
Discovery of a Chiral 2,4-Substituted Pyrrolo[2,3-<i>d</i>]pyrimidine as a Potent, Selective, and Orally Bioavailable LRRK2 Inhibitor
Journal of Medicinal Chemistry·2025· 1 cited
4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses
Journal of Medicinal Chemistry·2024· 5 cited
High-Throughput cell-based immunofluorescence assays against influenza
SLAS DISCOVERY·2023· 8 citedOpen Access
Novel Compound Inhibitors of HIV-1NL4-3 Vpu
Viruses·2022· 5 citedOpen Access
Peer Review #2 of "Fighting SARS-CoV-2 with green seaweed Ulva sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in in vitro Vero-E6 cells assay (v0.1)"
2021· 1 citedOpen Access
Fighting SARS-CoV-2 with green seaweed <i>Ulva</i> sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in <i>in vitro</i> Vero-E6 cells assay
PeerJ·2021· 20 citedOpen Access
Novel compound inhibitors of HIV-1 <sub>NL4-3</sub> Vpu
2021· 1 citedOpen Access
A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion
Nature Communications·2021· 119 citedOpen Access
Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus
Antimicrobial Agents and Chemotherapy·2021· 12 citedOpen Access
Inhibition of the SET/MLL Histone Methyltransferase Complex as a Novel Epigenetic Targeted Therapy in Mixed Lineage Leukemia
The FASEB Journal·2021
Inhibiting SARS‐CoV‐2 infection with lysosomal alkalizers
The FASEB Journal·2021Open Access
Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors
Journal of Medicinal Chemistry·2021· 22 citedOpen Access
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Frontiers in Pharmacology·2021· 93 citedOpen Access
Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design
PLoS ONE·2021· 39 citedOpen Access
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
PLoS ONE·2020· 3 citedOpen Access
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
ACS Infectious Diseases·2020· 91 citedOpen Access
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
2020· 30 citedOpen Access
Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2020Open Access
page 1 of 2Next →

Frequent Co-authors

Lynn Rasmussen(22), Corinne E. Augelli‐Szafran(13), Mark J. Suto(12), Sixue Zhang(7), Ashish K. Pathak(7), Omar Moukha‐Chafiq(7), Joseph A. Maddry(6), Nicole N. Haese(6), Daniel N. Streblow(6), Nichole A. Tower(6), Paul Shinn(5), Zina Itkin(5), Min Shen(5), Xin Hu(5), Anton Simeonov(5), Donald C. Lo(5), Matthew D. Hall(5), Wei Zheng(5), Vandana V. Gupta(5), N. Miranda Nebane(5)